Anca Avram, MD
Nuclear Medicine · Cleveland, OHNPI 1174616098
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,625 of the $10,683 with a category attached, or 71.4%. E.r. Squibb & Sons, L.L.C. accounts for 71.4% of it on its own, with 8 other manufacturers making up the rest.
Across 23 payments — averaging $464.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$8K
- Telix Pharmaceuticals$2K
- GE HealthCare$165
- Dexcom, Inc.$165
- Sanofi-aventis U.S. LLC$162
- Xeris Pharmaceuticals, Inc.$134
- plus $134 from 3 others
What the payments were for
- Consulting fees$7,62571%
- Travel & lodging$1,90718%
- Food & beverage$1,10810%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 6 | $7,625 |
| Telix Pharmaceuticals | 7 | $2,298 |
| GE HealthCare | 1 | $165 |
| Dexcom, Inc. | 2 | $165 |
| Sanofi-aventis U.S. LLC | 1 | $162 |
| Xeris Pharmaceuticals, Inc. | 3 | $134 |
| Sanofi | 1 | $56 |
| AstraZeneca | 1 | $43 |
| Tandem Diabetes Care, Inc. | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUCCIX$2,030
- DEXCOM G7 GSS (161)$125
How this compares
Too few nuclear medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $110 |
Paid to pharmacies, not to this prescriber.
Other nuclear medicine in Cleveland
- Manuel CerqueiraCleveland$160K
- Norbert AvrilCleveland$4K
- Jon KotlerColumbus$556
- Martin JacobsKettering$234
- Michael GelfandCincinnati$135
- Nishanta BaidyaDayton$74
- Benedict KimCanton$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.